Akero Therapeutics logo
Akero Therapeutics AKRO
$ 32.84 5.24%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Akero Therapeutics EV/EBITDA Ratio 2011-2024 | AKRO

Annual EV/EBITDA Ratio Akero Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.64 -10.2 -6.8 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-4.64 -10.2 -7.21